Marginal Zone Lymphoma Subtypes 📊

This presentation delves into the complexities of managing Marginal Zone Lymphoma (MZL), a challenging subtype in lymphoma treatment. After defining MZL and outlining current challenges, it will address existing treatment strategies, highlighting the prolonged control in early stages but limited options for relapse. The session will explore innovations like bispecific antibodies and antibody-drug conjugates, offering new hope. Key insights into the unique biology of MZL and the necessity for...